|Product type||Dietary supplements|
|Owner||Iovate Health Sciences Inc.|
|Discontinued||Recalled 2009 (placed back on market in 2010)|
|Related brands||List of brand names|
|Registered as a trademark in||September 1, 2010
|Tagline||Lose Weight Your Way.|
Hydroxycut is a brand of dietary supplements that is marketed as a weight loss aid. Hydroxycut was originally developed and manufactured by MuscleTech Research and Development; MuscleTech was sold to Iovate Health Sciences in 2003–2004 and declared bankruptcy in 2005; Iovate continues to use MuscleTech as a brand to market Hydroxycut.
Since 2013, the primary ingredients in the product line include caffeine, lady's mantle extract (Alchemilla vulgaris), wild olive extract (Olea europaea), cumin extract (Cuminum cyminum), wild mint extract (Mentha longifolia), and, in some products, green coffee bean extract (Coffea canephora).
Before the 2004 reformulation, formulations contained ephedra, a supplement banned by the FDA in 2004. Before the 2009 reformulation, formulations contained several substances with potential to harm the liver. After a series of reports in the medical literature of serious liver problems, including one death, the FDA warned consumers to stop using Hydroxycut, and Iovate agreed to voluntarily recall the products.
Marketing and sales
Hydroxycut is sold at conventional retailers, online retailers, and through direct television marketing. Like many dietary supplements, published studies demonstrating scientific evidence of its effectiveness and safety is lacking.
In March 2013, Sean Lowe became the brand ambassador for Hydroxycut Hardcore. In the same month, IndyCar racer Tony Kanaan announced he will pilot the No. 11 Hydroxycut IndyCar at the Indianapolis 500 along with 8 other events at the 2013 IndyCar Championship. Hydroxycut has been promoted as being created and endorsed by doctors. Television advertisements for Hydroxycut featured a medical resident, although reporters were unable to locate him after Hydroxycut was removed from the market in 2009.
MuscleTech Research and Development Inc was a Canadian company based in Toronto that operated with a group of closely related companies, and developed the Hydroxycut product line.:499 Thousands of lawsuits were filed over ephedra in the early 2000s; the first lawsuits against MuscleTech began in 2000 and by 2004 there were about 80 pending.:503 In 2003 and 2004, most of the assets of the MuscleTech group of companies were sold off to other companies, including Iovate Health Sciences; the same person controlled MuscleTech and Iovate.:503–504 MuscleTech filed for bankruptcy in June 2005:499 and the claims of litigants against MuscleTech were resolved by 2007.:515 Since then, MuscleTech has become a brand of Iovate, under which Hydroxycut products are sold.
Prior to 2004, some formulations of Hydroxycut contained ephedra. There were reports of seizures in people who had ingested Hydroxycut, which were attributed to the ephedra and caffeine in the product. As a result, there were around 80 pending ephedra lawsuits against MuscleTech.
In 2003, Missouri Attorney General Jay Nixon filed a lawsuit in St. Louis against Hydroxycut's manufacturer, MuscleTech, stating that its marketing claims that Hydroxycut was "clinically proven" to be a "fat-burner" were false. Nixon also alleged that "MuscleTech's own consultants had serious concerns about the safety of Hydroxycut, but the company continued to market the product." MuscleTech paid $100,000 to settle the case and agreed to cease marketing ephedra-containing products in Missouri and to refund customers' money.
The New York Times reported in 2003 that internal documents from MuscleTech indicated that the company had buried studies showing that Hydroxycut was ineffective, covered up evidence of cardiac side effects, and even tampered with the documents it submitted as evidence in a lawsuit in Oklahoma.
In 2004, the FDA banned ephedra after 155 deaths from heart attack and stroke were attributed to ephedra, including the death of Baltimore Orioles pitcher Steve Bechler. It was the first banning of a dietary supplement by the FDA.
By 2009, about 15% of Americans had tried taking dietary supplements for weight loss, and Hydroxycut was the biggest seller, with about a million units sold each year.
Scientific evidence of serious side effects from Hydroxycut products accumulated, including liver failure (requiring liver transplantation in some cases), rhabdomyolysis, and at least one death, of a 19-year-old man who used the product.
On May 1, 2009, the U.S. Food and Drug Administration (FDA) issued a warning to consumers to stop using Hydroxycut products, due to 23 reports of serious health problems associated with the use of Hydroxycut, and at least one death, and to destroy any product that they may possess. The warning stated "Although the liver damage appears to be relatively rare, FDA believes consumers should not be exposed to unnecessary risk. Consumers who have these products are urged to stop using them." Following the FDA warning, the manufacturer then agreed to voluntarily recall the products.
As of 2013, its primary ingredients include caffeine anhydrous, Lady's mantle extract (Alchemilla vulgaris), Wild olive extract (Olea europaea), Cumin extract (Cuminum cyminum), Wild mint extract (Mentha longifolia) and, in some Hydroxycut products, Green coffee bean extract (Coffea canephora robusta).
Following the reformulation, case reports in the medical literature have continued to link Hydroxycut to serious side effects. An article published in 2010 reported on a case of atrial fibrillation that the author suspected was due to epigallocatechin gallate in Hydroxycut Green Tea, a product that as of 2012 is no longer marketed. Another case published in 2013 reported on a patient who developed ulcerative colitis due to Hydroxycut Hardcore.
The Hydroxycut case has been cited as emblematic of the weak regulation of dietary supplements in the U.S. Defenders of the nutritional supplements industry said that the recall demonstrated that the FDA has the power to protect consumers from toxic products, while critics cited it as evidence that the FDA's powers over dietary supplements need to be expanded.
While some diet supplement executives defended the safety of Hydroxycut and believed the media "over-hyped" the FDA withdrawal, others questioned why Iovate had not published long-term safety or efficacy studies on the final Hydroxycut products, and used weak trial duration and sample sizes. This is despite having the money to perform such studies and their self-definition as a "research-oriented" company. The editors of the nutrition trade journal Nutrition Business Journal noted that this recall "will ultimately be a good thing for the dietary supplement industry if it encourages weight-loss supplement manufacturers to care as much about their products' safety and efficacy as they do about expanding and protecting their bottom lines."
In a paper published in the World Journal of Gastroenterology in October 2010, Hydroxycut was cited as an example of "current and former weight loss products backed by potentially conflicted or low quality research." It noted that "Marketing materials for Hydroxycut cited two published studies asserting product effectiveness that were small, of short duration, reported no serious side effects, and did not disclose relationships between authors and the product manufacturer or that funding was received from the product manufacturer."
The paper noted that at least three studies supported the safety and effectiveness for weight loss of Cissus quadrangularis (CQ), which is an ingredient used in one of the reformulated Hydroxycut products, but "lack financial disclosures or funding sources, beyond mentioning that the CQ being tested was provided by" General Health Alliances, an herbal products manufacturer. The studies did not disclose that one of its authors was a chief scientific officer for GHA that holds a patent on a CQ product.
- "About Hydroxycut". Ostrofflaw. Retrieved 29 March 2013.
- "Television Personality Sean Lowe is new Brand Ambassador for Hydroxycut Hardcore™ - Will Help Provide Energy for Dancing with the Stars". Cision. March 12, 2013. Retrieved 29 March 2013.
- "FDA Issues Regulation Prohibiting Sale of Dietary Supplements Containing Ephedrine". FDA. 6 February 2004.
- "FDA Warns Consumers to Stop Using Hydroxycut Products". U.S. Food and Drug Administration.
- Lobb, Anno (14 October 2010). "Science of weight loss supplements: Compromised by conflicts of interest?". World Journal of Gastroenterology 16 (38): 4880–4882. doi:10.3748/wjg.v16.i38.4880. PMC 2955261. PMID 20939120.
- "Weight-Loss Supplement Sales Plummet Following Iovate's Hydroxycut Recall". Nutrition Business Journal.
- Fessenden, Ford (June 23, 2003). "Studies of Dietary Supplements Come Under Growing Scrutiny". The New York Times. Retrieved 2009-05-02.
- Frank, Hoffman. "Sean Lowe is Hydroxycut Hardcore’s New Dancing Star". Muscle Maf. Retrieved 30 April 2013.
- "Hydroxycut supports Tony Kanaan". Nationalspeed Sports News. Retrieved 14 May 2013.
- "KV Racing signs sponsor in time for season opener". Washington Post. Retrieved 14 May 2013.
- Peck, Peggy (May 9, 2009). "I'm Not a Doctor, but...". ABC News. Retrieved March 11, 2013.
- Jeffrey Carhart "Reflections on the MuscleTech Case" Annual Review of Insolvency Law. March 4, 2009, pp. 499–516
- "rown Rudnick Prevails on Behalf of Creditors in Metabolife Chapter 11 Bankruptcy Proceedings". Business Wire. November 13, 2006. Retrieved October 27, 2015.
- Iovate's Linked-in page
- Staff, BloombergBusinessWeek. Company Overview of Iovate Health Sciences, Inc. Accessed March 30, 2013
- Staff, BloombergBusinessWeek. Company Overview of Kerr Investment Holding Corp. Accessed March 31, 2013
- Kockler DR, McCarthy MW, Lawson CL (2001). "Seizure activity and unresponsiveness after hydroxycut ingestion.". Pharmacotherapy 21 (5): 647–51. doi:10.1592/phco.21.6.647.34542. PMID 11349754.
- "Nixon sues maker of Hydroxycut". St. Louis Business Journal. March 27, 2003. Retrieved April 18, 2012.
- "'20/20' Investigates Diet Pill Ads". 20/20 (ABC News). Retrieved April 18, 2012.
- "Hydroxycut distributor to pay Missouri $100K to settle suit". St. Louis Business Journal. May 4, 2004. Retrieved April 18, 2012.
- "Hydroxycut: What You Need to Know". Sarah Siddons. How Stuff Work. Retrieved 29 March 2013.
- Death at the ballpark: a comprehensive study of game-related fatalities of … By Robert M. Gorman, David Weeks. McFarland Press. p. 64.
- Ano Lobb (2009-04-14). "Hepatoxicity associated with weight-loss supplements: A case for better post-marketing surveillance". World J Gastroenterol 15 (14): 1786–7. doi:10.3748/wjg.15.1786. PMC 2668789. PMID 19360927.
- Dara L, Hewett J, Lim JK (2008). "Hydroxycut hepatotoxicity: a case series and review of liver toxicity from herbal weight loss supplements". World J Gastroenterol 14 (45): 6999–7004. doi:10.3748/wjg.14.6999. PMC 2773866. PMID 19058338.
- Richwine, Lias (May 1, 2009). "Hydroxycut products recalled after one death". Reuters. Retrieved March 11, 2013.
- Dehoney S, Wellein M (2009). "Rhabdomyolysis associated with the nutritional supplement Hydroxycut.". Am J Health Syst Pharm 66 (2): 142–8. doi:10.2146/ajhp070640. PMID 19139478.
- Fong, TL; Klontz, KC; Canas-Coto, A; Casper, SJ; Durazo, FA; Davern Tj, 2nd; Hayashi, P; Lee, WM; Seeff, LB (2010). "Hepatotoxicity due to hydroxycut: a case series". The American Journal of Gastroenterology 105 (7): 1561–6. doi:10.1038/ajg.2010.5. PMC 3825455. PMID 20104221.
- Norton, Amy (February 12, 2010). "Hydroxycut linked to other cases of liver damage". Reuters Health (New York: Reuters). Retrieved December 9, 2010.
- Rashid NN, Grant J (2010). "Hydroxycut hepatotoxicity.". Med. J. Aust. 192 (3): 173–4. PMID 20121691.
- Sharma, T.; Wong, L.; Tsai, N.; Wong, R. D. (2010). "Hydroxycut® (herbal weight loss supplement) Induced Hepatotoxicity: A Case Report and Review of Literature". Hawaii Medical Journal 69 (8): 188–190. PMC 3118021. PMID 20845283.
- Associated Press (May 1, 2009). "FDA warns dieters: Stop Hydroxycut use now". MSNBC. Retrieved 2009-05-02.
- "FDA Safety Recall". FDA. Retrieved 16 May 2013.
- Edwards, Jim. "How Hydroxycut Stays in Business Despite Deaths, Recalls and a Class-Action Suit". CBS News. Retrieved March 11, 2013.
- Lorraine Heller for NutraIngredients-USA.com, September 8, 2009. Reformulated Hydroxycut back on shelves
- Smith, Michael W. (28 February 2013). "Hydroxycut: Uses, Side Effects, and Risks". WebMD. Retrieved 21 March 2013.
- Karth A, Holoshitz N, Kavinsky CJ, Trohman R, McBride BF (2010). "A case report of atrial fibrillation potentially induced by hydroxycut: a multicomponent dietary weight loss supplement devoid of sympathomimetic amines". J Pharm Pract 23 (3): 245–9. doi:10.1177/0897190010362104. PMID 21507821.
- Hydroxycut Green Tea Review. Accessed March 30, 2013
- Sivarajah V, Abdul Q, Pardoe H, Lunniss P (2013). "Ulcerative colitis associated with the herbal weight loss supplement Hydroxycut". BMJ Case Rep 2013: bcr2012007509. doi:10.1136/bcr-2012-007509. PMID 23291814.
- Fiore, Kristina (May 7, 2009). "Groups Call for Review of DSHEA in Light of Hydroxycut". MedPage Today. Retrieved March 11, 2013.
- Edwards, Jim (May 4, 2009). "Why Hydroxycut Had to Kill Someone Before the FDA Could Act". CBS News. Retrieved March 11, 2013.
- Healy, Melissa (25 May 2009). "Sizing up safety; If a bestselling weight-loss aid is recalled, does that mean oversight of the supplement industry is working? For consumers with few options, that's a tough call to make". Los Angeles Times.
- "Hydroxycut and PhenqAvis Phentermine". 3 March 2015.